Citigroup’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-352,641
| Closed | -$32.8M | – | 6842 |
|
|
2021
Q4 | $32.8M | Buy |
352,641
+309,051
| +709% | +$20.4M | 0.02% | 759 |
|
|
2021
Q3 | $2.6M | Sell |
43,590
-30,619
| -41% | -$1.81M | ﹤0.01% | 2327 |
|
|
2021
Q2 | $5.06M | Buy |
74,209
+9,362
| +14% | +$610K | ﹤0.01% | 1882 |
|
|
2021
Q1 | $4.5M | Sell |
64,847
-6,291
| -9% | -$484K | ﹤0.01% | 1856 |
|
|
2020
Q4 | $5.47M | Buy |
71,138
+11,546
| +19% | +$865K | ﹤0.01% | 2012 |
|
|
2020
Q3 | $4.46M | Buy |
59,592
+12,237
| +26% | +$816K | ﹤0.01% | 1960 |
|
|
2020
Q2 | $2.98M | Sell |
47,355
-32,917
| -41% | -$1.81M | ﹤0.01% | 2355 |
|
|
2020
Q1 | $3.37M | Buy |
80,272
+55,246
| +221% | +$2.53M | ﹤0.01% | 2017 |
|
|
2019
Q4 | $1.14M | Sell |
25,026
-47,373
| -65% | -$2.24M | ﹤0.01% | 3630 |
|
|
2019
Q3 | $3.31M | Buy |
72,399
+43,269
| +149% | +$2.43M | ﹤0.01% | 2325 |
|
|
2019
Q2 | $1.71M | Buy |
29,130
+11,500
| +65% | +$594K | ﹤0.01% | 3041 |
|
|
2019
Q1 | $790K | Sell |
17,630
-79,662
| -82% | -$3.65M | ﹤0.01% | 3669 |
|
|
2018
Q4 | $3.79M | Buy |
97,292
+71,795
| +282% | +$2.82M | ﹤0.01% | 2072 |
|
|
2018
Q3 | $1.17M | Buy |
25,497
+5,461
| +27% | +$221K | ﹤0.01% | 3310 |
|
|
2018
Q2 | $874K | Sell |
20,036
-55,344
| -73% | -$2.38M | ﹤0.01% | 3502 |
|
|
2018
Q1 | $2.98M | Buy |
75,380
+12,561
| +20% | +$489K | ﹤0.01% | 2254 |
|
|
2017
Q4 | $2.13M | Buy |
62,819
+11,894
| +23% | +$339K | ﹤0.01% | 2612 |
|
|
2017
Q3 | $1.3M | Buy |
50,925
+32,587
| +178% | +$747K | ﹤0.01% | 3104 |
|
|
2017
Q2 | $309K | Buy |
18,338
+7,461
| +69% | +$102K | ﹤0.01% | 4428 |
|
|
2017
Q1 | $158K | Sell |
10,877
-41,757
| -79% | -$619K | ﹤0.01% | 4855 |
|
|
2016
Q4 | $747K | Buy |
52,634
+43,424
| +471% | +$673K | ﹤0.01% | 3981 |
|
|
2016
Q3 | $160K | Buy |
9,210
+2,873
| +45% | +$47.6K | ﹤0.01% | 4843 |
|
|
2016
Q2 | $109K | Sell |
6,337
-12,574
| -66% | -$225K | ﹤0.01% | 5012 |
|
|
2016
Q1 | $373K | Buy |
18,911
+15,624
| +475% | +$250K | ﹤0.01% | 4461 |
|
|
2015
Q4 | $63K | Sell |
3,287
-27,865
| -89% | -$568K | ﹤0.01% | 5759 |
|
|
2015
Q3 | $595K | Buy |
31,152
+27,848
| +843% | +$946K | ﹤0.01% | 3579 |
|
|
2015
Q2 | $153K | Sell |
3,304
-1,727
| -34% | -$74.9K | ﹤0.01% | 4666 |
|
|
2015
Q1 | $219K | Sell |
5,031
-4,088
| -45% | -$190K | ﹤0.01% | 4449 |
|
|
2014
Q4 | $317K | Buy |
9,119
+8,062
| +763% | +$327K | ﹤0.01% | 4300 |
|
|
2014
Q3 | $44K | Sell |
1,057
-58
| -5% | -$2.59K | ﹤0.01% | 5392 |
|
|
2014
Q2 | $65K | Sell |
1,115
-4,754
| -81% | -$299K | ﹤0.01% | 4983 |
|
|
2014
Q1 | $370K | Sell |
5,869
-7,237
| -55% | -$480K | ﹤0.01% | 3765 |
|
|
2013
Q4 | $767K | Buy |
13,106
+7,800
| +147% | +$408K | ﹤0.01% | 3429 |
|
|
2013
Q3 | $279K | Sell |
5,306
-1,397
| -21% | -$93.8K | ﹤0.01% | 3889 |
|
|
2013
Q2 | $516K | Buy |
+6,703
| New | +$547K | ﹤0.01% | 3461 |
|
Citigroup's ARNA Position: Q1 2022 in Review
Citigroup sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 352,641 shares — an estimated $32.8M sold.
Citigroup first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $32.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Citigroup reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Citigroup sold 352,641 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $32.8M.
- Citigroup first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Citigroup's Arena Pharmaceuticals Inc position peaked at $32.8M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.